Global Active Pharmaceutical Ingredient (API) Market Growth 2023-2029

Global Active Pharmaceutical Ingredient (API) Market Growth 2023-2029

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

LPI (LP Information)' newest research report, the “Active Pharmaceutical Ingredient (API) Industry Forecast” looks at past sales and reviews total world Active Pharmaceutical Ingredient (API) sales in 2022, providing a comprehensive analysis by region and market sector of projected Active Pharmaceutical Ingredient (API) sales for 2023 through 2029. With Active Pharmaceutical Ingredient (API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Active Pharmaceutical Ingredient (API) industry.

This Insight Report provides a comprehensive analysis of the global Active Pharmaceutical Ingredient (API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Active Pharmaceutical Ingredient (API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Active Pharmaceutical Ingredient (API) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Active Pharmaceutical Ingredient (API) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Active Pharmaceutical Ingredient (API).

The global Active Pharmaceutical Ingredient (API) market size is projected to grow from US$ 70520 million in 2022 to US$ 112110 million in 2029; it is expected to grow at a CAGR of 112110 from 2023 to 2029.

India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.

This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredient (API) market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Anti-Infective
Hormonal
Others

Segmentation by application
Respiratory
Rheumatology
Diabetes
Oncology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

Key Questions Addressed in this Report

What is the 10-year outlook for the global Active Pharmaceutical Ingredient (API) market?

What factors are driving Active Pharmaceutical Ingredient (API) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Active Pharmaceutical Ingredient (API) market opportunities vary by end market size?

How does Active Pharmaceutical Ingredient (API) break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.